The Pfizer vaccine specific for the Omicron variant will be ready by March. This was announced by Albert Bourla, CEO of the US pharmaceutical giant, in an interview with Cnbc. The company has already started producing dosesBourla explained, adding that the vaccine will also affect other variants in circulation.
“There hope is to be able to get a product that will have better protection especially against infection, because protection against hospitalization and severe illness is reasonable right now, with the vaccines currently available, as long as you have the third dose, ”Bourla said.
EMA EVALUATES ANTI COVID PFIZER DRUG
Meanwhile, the European drug agency is evaluating the authorization application for the antiviral Paxlovid, Pfizer’s drug, for the treatment of Covid-19 in adults and adolescents. Ema herself announces it. The response should arrive within weeks.
#Omicron #variant #Pfizer #Vaccine #ready #March